1. Home
  2. SACH vs TENX Comparison

SACH vs TENX Comparison

Compare SACH & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.06

Market Cap

50.6M

Sector

Real Estate

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$14.38

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SACH
TENX
Founded
2010
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
56.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SACH
TENX
Price
$1.06
$14.38
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$2.00
$22.50
AVG Volume (30 Days)
141.8K
333.5K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
18.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,906,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$4.63
52 Week High
$1.35
$18.38

Technical Indicators

Market Signals
Indicator
SACH
TENX
Relative Strength Index (RSI) 52.28 52.42
Support Level $1.03 $13.84
Resistance Level $1.07 $15.64
Average True Range (ATR) 0.02 1.51
MACD 0.00 -0.27
Stochastic Oscillator 57.14 28.76

Price Performance

Historical Comparison
SACH
TENX

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: